European device classification guidance "skips contentious issues"
This article was originally published in RAJ Devices
The European Commission's latest revision of its guidance on the classification of medical devices fails to address some controversial issues, according to medtech industry association Eucomed and standards body BSI1-3.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.